DRI Capital
Overview
DRI Capital is a Canadian private investment firm specializing in pharmaceutical and biotechnology royalty streams. The firm focuses on acquiring existing royalty streams and revenue interests derived from products in the life sciences industry from inventors, academic and research institutions, or companies. DRI Capital manages two funds: the Royalty Monetization Fund and the Structured Finance Fund. The Royalty Monetization Fund acquires existing royalty streams at competitive rates, while the Structured Finance Fund provides non-dilutive financing for product acquisitions, launches, mergers and acquisitions, in-licensing, sales force expansion, and general working capital purposes to companies within the healthcare industry. DRI Capital has been instrumental in creating a robust and liquid market for the recipients of royalties on healthcare-related products. Over the years, the firm has completed numerous royalty transactions and purchased royalty entitlements, holding a diversified portfolio of healthcare royalty entitlements. The company's investment strategy aims to provide risk-mitigated exposure across multiple therapeutic areas, generating attractive returns and sustainable growth for stakeholders. DRI Capital's track record includes significant investments in leading pharmaceutical products, contributing to the advancement of medical treatments and innovations in the healthcare sector.
Investment Focus
- Established pharmaceutical or biotechnology companies with existing royalty streams
- Innovative products with strong market potential
- Opportunities for non-dilutive financing in the healthcare industry
- Companies seeking capital for product acquisitions, launches, or general working capital purposes
Portfolio Companies
Get the full list of 54,000+ investors
DRI Capital and every other firm and angel in the database — as one spreadsheet you keep.
$19one-time payment · no subscription- All 54,000+ investors — VC firms, private equity, family offices and angels
- The key person to contact at each one, with their job title
- Their work email address
- Their phone number
- Their LinkedIn profile
- Delivered as a single .xlsx file — download it as many times as you like
Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.
Frequently asked questions about DRI Capital
What sectors does DRI Capital invest in?
DRI Capital invests in Financial Services, Technology, Healthcare, Energy, Telecommunications and Media, and is based in Toronto, Ontario, Canada. DRI Capital is listed as a private investment firm in the ConnectSafely investor database.
What stage does DRI Capital invest at?
DRI Capital backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 1M - 50M.
Which regions does DRI Capital invest in?
DRI Capital invests across United States, Canada, Hong Kong, Japan, Australia and Europe.
Who are the partners at DRI Capital?
Team members listed for DRI Capital include Faith Bowen (Chief Compliance Officer) and Ben Axler (Director, Investment Team).
What companies has DRI Capital invested in?
DRI Capital's portfolio includes Enbrel, FluMist, Preotact and PEG-INTRON.
How do I contact DRI Capital?
DRI Capital's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database